Skip to main content
A report of the pros and cons of extending the federal Medicaid drug rebate to managed care plans shows the potential for savings of up to $700 million over 10 years, but also recognizes that there could be some downside risk to plans and each one would have to evaluate the advantages and disadvantages of having access to the rebate if the rules were changed.

Should MCOs get the Medicaid drug rebate?